Clinical trial
Four-week Duration Versus 6-week Duration of Therapy for the Treatment of Enterococcal Endocarditis
NCT05398289 is registered in ClinicalTrials.gov with University Magna Graecia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Four-week Duration Versus 6-week Duration of Therapy for the Treatment of Enterococcal Endocarditis
- Lead sponsor
- University Magna Graecia
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- January 1, 2024
- Completion date
- September 1, 2026
- Enrollment
- 130 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
enterococcal endocarditis